626 related articles for article (PubMed ID: 30578107)
21. Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis.
Hanafy AS; Abd-Elsalam S; Dawoud MM
Vascul Pharmacol; 2019 Feb; 113():86-91. PubMed ID: 29886103
[TBL] [Abstract][Full Text] [Related]
22. Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver.
Rosenqvist K; Eriksson LG; Rorsman F; Sangfelt P; Nyman R
Acta Radiol; 2016 May; 57(5):572-9. PubMed ID: 26253926
[TBL] [Abstract][Full Text] [Related]
23. Anticoagulation therapy early is safe in portal vein thrombosis patients with acute variceal bleeding: a multi-centric randomized controlled trial.
Gao Z; Li S; Zhao J; Li J; Gao Y
Intern Emerg Med; 2023 Mar; 18(2):513-521. PubMed ID: 36692588
[TBL] [Abstract][Full Text] [Related]
24. Management of portal vein thrombosis in liver cirrhosis.
Qi X; Han G; Fan D
Nat Rev Gastroenterol Hepatol; 2014 Jul; 11(7):435-46. PubMed ID: 24686266
[TBL] [Abstract][Full Text] [Related]
25. Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis.
Chung JW; Kim GH; Lee JH; Ok KS; Jang ES; Jeong SH; Kim JW
Clin Mol Hepatol; 2014 Dec; 20(4):384-91. PubMed ID: 25548745
[TBL] [Abstract][Full Text] [Related]
26. Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis.
Luca A; Miraglia R; Caruso S; Milazzo M; Sapere C; Maruzzelli L; Vizzini G; Tuzzolino F; Gridelli B; Bosch J
Gut; 2011 Jun; 60(6):846-52. PubMed ID: 21357252
[TBL] [Abstract][Full Text] [Related]
27. Low-molecular-weight heparin treatment for portal vein thrombosis in liver cirrhosis: Efficacy and the risk of hemorrhagic complications.
Kwon J; Koh Y; Yu SJ; Yoon JH
Thromb Res; 2018 Mar; 163():71-76. PubMed ID: 29407630
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis.
Chen H; Liu L; Qi X; He C; Wu F; Fan D; Han G
Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):82-9. PubMed ID: 26513611
[TBL] [Abstract][Full Text] [Related]
29. Emergency anticoagulation treatment for cirrhosis patients with portal vein thrombosis and acute variceal bleeding.
Maruyama H; Takahashi M; Shimada T; Yokosuka O
Scand J Gastroenterol; 2012 Jun; 47(6):686-91. PubMed ID: 22472055
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of anticoagulants in liver cirrhosis patients with portal vein thrombosis: A meta-analysis.
Gao Y; Liu H; Tang F; Zhang X; Li F; Ye Q; Yuan H; Lv H; Han T
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101649. PubMed ID: 33601064
[TBL] [Abstract][Full Text] [Related]
31. Portal vein thrombosis in cirrhotic patients - it is always the small pieces that make the big picture.
Gîrleanu I; Trifan A; Stanciu C; Sfarti C
World J Gastroenterol; 2018 Oct; 24(39):4419-4427. PubMed ID: 30356984
[TBL] [Abstract][Full Text] [Related]
32. Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients.
Hayashi T; Takatori H; Horii R; Nio K; Terashima T; Iida N; Kitahara M; Shimakami T; Arai K; Kitamura K; Kawaguchi K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Toyama T; Okumura K; Kozaka K; Kaneko S
BMC Gastroenterol; 2019 Dec; 19(1):217. PubMed ID: 31842768
[TBL] [Abstract][Full Text] [Related]
33. Management of portal vein thrombosis in cirrhosis: an update.
Mancuso A
Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):739-43. PubMed ID: 27075588
[TBL] [Abstract][Full Text] [Related]
34. Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis.
Guerrero A; Campo LD; Piscaglia F; Scheiner B; Han G; Violi F; Ferreira CN; Téllez L; Reiberger T; Basili S; Zamora J; Albillos A;
J Hepatol; 2023 Jul; 79(1):69-78. PubMed ID: 36858157
[TBL] [Abstract][Full Text] [Related]
35. A systematic review and meta-analysis of anticoagulation therapy for portal vein thrombosis in patients with cirrhosis: to treat or not to treat?
Dong S; Qi H; Li Y; Men P; Alifu M; Zhang Y; Li Y; Zhao R
Hepatol Int; 2021 Dec; 15(6):1356-1375. PubMed ID: 34487316
[TBL] [Abstract][Full Text] [Related]
36. Acute mesenteric vein thrombosis after endoscopic injection sclerotherapy for esophageal varices in a patient with liver cirrhosis.
Wang L; Xu X; Hou Y; Shao X; Guo X; Qi X
Drug Discov Ther; 2019; 13(2):118-121. PubMed ID: 31080203
[TBL] [Abstract][Full Text] [Related]
37. Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation.
Werner KT; Sando S; Carey EJ; Vargas HE; Byrne TJ; Douglas DD; Harrison ME; Rakela J; Aqel BA
Dig Dis Sci; 2013 Jun; 58(6):1776-80. PubMed ID: 23314858
[TBL] [Abstract][Full Text] [Related]
38. The Efficacy and Safety of Anticoagulants in the Treatment of Cirrhotic Portal Vein Thrombosis: A Systematic Review and Meta-Analysis.
Zhang Z; Zhao Y; Han B; Zhu Z; Sun L; Cui X
Clin Appl Thromb Hemost; 2022; 28():10760296221104797. PubMed ID: 35656719
[TBL] [Abstract][Full Text] [Related]
39. Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate.
Faccia M; Ainora ME; Ponziani FR; Riccardi L; Garcovich M; Gasbarrini A; Pompili M; Zocco MA
World J Gastroenterol; 2019 Aug; 25(31):4437-4451. PubMed ID: 31496623
[TBL] [Abstract][Full Text] [Related]
40. Anticoagulation in Cirrhosis: Evidence for the Treatment of Portal Vein Thrombosis and Applications for Prophylactic Therapy.
Martens K; McMurry HS; Koprowski S; Hum J; Haraga J; Jou JH; Shatzel JJ
J Clin Gastroenterol; 2022 Jul; 56(6):536-545. PubMed ID: 35537133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
